Insider at Recro Pharma (REPH) Makes Significant Sale of Stock

Friday, November 24, 2017 10:15 PM ET

Insider at Recro Pharma (REPH) Makes Significant Sale of Stock

One Recro Pharma insider — Broadfin Healthcare Master Fund Ltd, 10% Owner — today, sold 172,208 shares having a market value of approximately $1,626,565, as disclosed in a form 4 document filed with the SEC. This is the first insider buy/sell trade in the past 90 days.

The level of buy-sell trades at Recro Pharma is close to that of the 272 member peer company average. The Bio Therapeutic Drugs peer group saw 327 buy/sell trades during this period for an average of 1.2 transactions per company. However, trading at Recro Pharma represents a lower number of shares per transaction. Within the peer group there were 36,993,200 shares purchased and 39,972,590 shares sold with company insiders disposing of 9,111 shares on average over this time period.

Insider buying and selling activity that is significant has been determined by eliminating all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers in composing and writing this story.

Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.

For more information, contact UpTick at info@uptickdata.com. Copyright 2017 UpTick Data Technologies. All rights reserved.

This entry was posted in InsiderNews and tagged , , , , . Bookmark the permalink.